Human Herpesvirus Infections

Tropical Infectious Diseases

Volumn 1, Issue , 2006, Pages 590-620

  Hudnall, S David ^a   Stanberry, Lawrence R ^b,c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b Department of Pediatrics ^*  (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882511924     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06668-9.50062-4     Document Type: Chapter

References (501)

1. Fields' Virology 1996, Lippincott-Raven, Philadelphia. 3rd ed. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
2. Principles and Practice of Infectious Diseases 1995, Churchill Livingstone, New York. 4th ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
3. Webster RG, Granoff A Encyclopedia of Virology 1994, Academic Press, San Diego.
4. Roizman B, Whitley RJ, Lopez C The Human Herpesviruses 1993, Raven Press, New York.
5. Evans AS Viral Infections of Humans-Epidemiology and Control 1989, Plenum Press, New York. 3rd ed.
6. Tyring SK Infections involving the skin. Clinical Dermatology New York 1997, 127. Churchill Livingston. D.D. Richman, R.J. Whitley, F.G. Hayden (Eds.).
7. Tyring SK Newer aspects of herpesvirus infections. Curr Opin Dermatol 1997, 4:42.
8. Reusser P Herpesvirus resistance to antiviral drugs: A review of the mechanisms, clinical importance and therapeutic options. J Hosp Infect 1996, 33:235.
9. Lowenstein A Aetiologische Untersuchungen Über den fieberhaften Herpes. Munch Med Wochenschr 1919, 66:769.
10. Nahmias AJ, Dowdle WR Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol 1968, 10:110.
11. Yoshikawa T, Hill JM, Stanberry LR, et al. The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J Exp Med 1996, 184:659.
12. Roizman B, Knipe DM Herpes simplex viruses and their replication. Fields' Virology 2001, 2399. Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
13. Read GS, Frenkel N Herpes simplex virus mutants defective in the virion associated shut-off of host polypeptide synthesis and exhibiting abnormal synthesis of a (immediate early) viral polypeptides. J Virol 1983, 46:498.
14. Spear PG, Longnecker R Herpesvirus entry: An update. J Virol 2003, 77:10179.
15. Bergstrom T, Trybala E Antigenic differences between HSV-1 and HSV-2 glycoproteins and their importance for type-specific serology. Intervirology 1996, 39:176.
16. Roizman B, Roane PR Multiplication of herpes simplex virus. II. The relationship between protein synthesis and the duplication of viral DNA in infected Hep-2 cells. Virology 1964, 22:262.
17. Roizman B, Borman GS, Kamali-Rousta M Macromolecular synthesis in cells infected with herpes simplex virus. Nature 1965, 206:1374.
18. Whitley RJ, Gnann JW The epidemiology and clinical manifestations of herpes simplex virus infections. The Human Herpesviruses 1993, 69. Raven Press, New York. B. Roizman, R.J. Whitley, C. Lopez (Eds.).
19. Smith JS, Robinson NJ Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review. J Infect Dis 2002, 186(Suppl 1):S3.
20. Cesario TC, Poland JD, Wulff H, et al. Six years experiences with herpes simplex virus in a children's home. Am J Epidemiol 1969, 90:416.
21. Buddingh GH, Schrum DI, Lanier JC, et al. Studies of the natural history of herpes simplex infections. Pediatrics 1953, 11:595.
22. DeGiordana HM, Banza CA, Russi JC, et al. Prevalence of herpes simplex virus infection. Arch Pediatr Uruguay 1970, 41:107.
23. Schmitt DL, Johnson DW, Henderson FW Herpes simplex type 1 infections in group day care. Pediatr Infect Dis J 1991, 10:729.
24. Scott TF, Steigman AJ, Convey JH Acute infectious gingivostomatitis: Etiology, epidemiology, and clinical pictures of a common disorder caused by the virus of herpes simplex. JAMA 1941, 117:999.
25. McMillan JA, Weiner LB, Higgins AM, et al. Pharyngitis associated with herpes simplex virus in college students. Pediatr Infect Dis 1993, 12:280.
26. Guex-Crosier Y, Rochat C, Herbort CP Necrotizing herpetic retinopathies. A spectrum of herpes virus-induced diseases determined by the immune state of the host. Ocul Immunol Inflamm 1997, 5:259.
27. Wollenberg A, Zoch C, Wetzel S, et al. Predisposing factors and clinical features of eczema herpeticum: A retrospective analysis of 100 cases. J Am Acad Dermatol 2003, 49:198.
28. Dworkin MS, Shoemaker PC, Spitters C, et al. Endemic spread of herpes simplex virus type 1 among adolescent wrestlers and their coaches. Pediatr Infect Dis J 1999, 18:1108.
29. Avitzur Y, Amir J Herpetic whitlow infection in a general pediatrician-An occupational hazard. Infection 2002, 30:234.
30. Kimberlin DW Herpes simplex virus infections of the central nervous system. Semin Pediatr Infect Dis 2003, 14:83.
31. Devine SM, Wingard JR Viral infections in severely immunocompromised cancer patients. Support Care Cancer 1994, 2:355.
32. Kang AH, Graves CR Herpes simplex hepatitis in pregnancy: A case report and review of the literature. Obstet Gynecol Surv 1999, 54:463.
33. Kalinyak JE, Fleagle G, Docherty JJ Incidence and distribution of herpes simplex virus types 1 and 2 from genital lesions in college women. J Med Virol 1977, 1:173.
34. Wolontis S, Jeansson S Correlation of herpes simplex virus types 1 and 2 with clinical features of infection. J Infect Dis 1977, 135:28.
35. Reeves WC, Corey L, Adams HG, et al. Risk of recurrence after first episodes of genital herpes: Relation to HSV type and antibody response. N Engl J Med 1981, 305:315.
36. Corey L, Adams H, Brown A, et al. Genital herpes simplex virus infections: Clinical manifestations, course and complications. Ann Intern Med 1983, 98:958.
37. Mertz GJ, Rosenthal SL, Stanberry LR Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes?. Sex Transm Dis 2003, 30:801.
38. Ship II, Morris AL, Durocher RT, et al. Recurrent aphthous ulcerations and recurrent herpes labialis in a professional school student population. I. Experience. Oral Surg Oral Med Oral Pathol Radiol Endod 1960, 13:1191.
39. Ship II, Morris AL, Durocher RT, et al. Recurrent aphthous ulcerations and recurrent labialis in a professional school student population. IV Twelve month study of natural disease patterns. Oral Surg Oral Med Oral Pathol 1961, 14:39.
40. Josey WE, Nahmias AJ, Naib ZM The epidemiology of type-2 (genital) herpes simplex virus infections. Obstet Gynecol Surg 1972, 27:295.
41. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997, 337:1105.
42. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000, 342:844.
43. Yeager AS, Arvin AM Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics 1984, 73:188.
44. Brown ZA, Benedetti J, Ashley R, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991, 324:1247.
45. Schacker T, Zeh J, Hu HL, et al. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis 1998, 178:1616.
46. Augenbraun M, Corey L, Reichelderfer P, et al. Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women. Clin Infect Dis 2001, 33:885.
47. Koelle DM, Wald A Herpes simplex virus: The importance of asymptomatic shedding. J Antimicrob Chemother 2000, 45(Suppl T3):1.
48. Chatterjee A, Chartrand SA, Harrison CJ, et al. Severe intrauterine herpes simplex disease with placentitis in a newborn of a mother with recurrent genital infection at delivery. J Perinatol 2001, 21:559.
49. Francis DP, Herrmann KL, MacMahon JR, et al. Nosocomial and maternally acquired herpesvirus hominis infections. A report of four fatal cases in neonates. Am J Dis Child 1975, 129:889.
50. Hutto C, Arvin A, Jacobs R, et al. Intrauterine herpes simplex virus infections. J Pediatr 1987, 110:97.
51. Stanberry LR The pathogenesis of herpes simplex virus infections. Genital and Neonatal Herpes 1996, 31-48. John Wiley and Sons, London. L.R. Stanberry (Ed.).
52. Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001, 108:223.
53. Stanberry LR The pathogenesis of herpes simplex virus infections. Genital and Neonatal Herpes 1996, 31. John Wiley and Sons, London. L.R. Stanberry (Ed.).
54. Stevens JG, Wagner EK, Devi-Rao GB, et al. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 1987, 235:1056.
55. Croen KD, Ostrove JM, Dragovic LJ, et al. Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization. N Engl J Med 1987, 317:1427.
56. Cook ML, Stevens JG Pathogenesis of herpetic neuritis and ganglionitis in mice: Evidence of intra-axonal transport of infection. Infect Immun 1973, 7:272.
57. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000, 342:844.
58. Esmann J The many challenges of facial herpes simplex virus infection. J Antimicrob Chemother 2001, 47(Suppl T1):17.
59. York IA, Roop C, Andrew DW, et al. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8- T lymphocytes. Cell 1994, 77:525.
60. Hill A, Jugovic P, York I, et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995, 375:411.
61. Nagashunmugam T, Lubinski J, Wang L, et al. In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol 1998, 72:5351.
62. Favoreel HW, Nauwynck HJ, Pensaert MB Immunological hiding of herpesvirus-infected cells. Arch Virol 2000, 145:1269.
63. Friedman HM Immune evasion by herpes simplex virus type 1, strategies for virus survival. Trans Am Clin Climatol Assoc 2003, 114:103.
64. Koutsky LA, Stevens CE, Holmes KK, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 1992, 326:1533.
65. Langenberg AG, Corey L, Ashley RL, et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999, 341:1432.
66. Marshall DS, Linfert DR, Draghi A, et al. Identification of herpes simplex virus genital infection: Comparison of a multiplex PCR assay and traditional viral isolation techniques. Mod Pathol 2001, 14:152.
67. Verano L, Michalski FJ Comparison of a direct antigen enzyme immunoassay, Herpchek, with cell culture for detection of herpes simplex virus from clinical specimens. J Clin Microbiol 1995, 33:1378.
68. Slomka MJ, Emery L, Munday PE, et al. A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes. J Med Virol 1998, 55:177.
69. Bagg J, Mannings A, Munro J, et al. Rapid diagnosis of oral herpes simplex or zoster virus infections by immunofluorescence: Comparison with Tzanck cell preparations and viral culture. Br Dent J 1989, 167:235.
70. Aurelius E, Johansson B, Skoldenberg B, et al. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet 1991, 337:189.
71. Domingues RB, Lakeman FD, Mayo MS, et al. Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis. J Clin Microbiol 1998, 36:2229.
72. Koenig M, Reynolds KS, Aldous W, et al. Comparison of Light-Cycler PCR, enzyme immunoassay, and tissue culture for detection of herpes simplex virus. Diagn Microbiol Infect Dis 2001, 40:107.
73. Ashley RL Performance and use of HSV type-specific serology test kits. Herpes 2002, 9:38.
74. Ashley RL Sorting out the new HSV type specific antibody tests. Sex Transm Infect 2001, 77:232.
75. Villarreal EC Current and potential therapies for the treatment of herpes-virus infections. Prog Drug Res 2003, 60:263.
76. Bacon TH, Levin MJ, Leary JJ, et al. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev 2003, 16:114.
77. Chilukuri S, Rosen T Management of acyclovir-resistant herpes simplex virus. Dermatol Clin 2003, 21:311.
78. Safrin S, Kemmerly S, Plotkin B, et al. Foscarnet-resistant herpes simplex virus infection in patients with AIDS. J Infect Dis 1994, 169:193.
79. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001, 285:3100.
80. Casper C, Wald A Condom use and the prevention of genital herpes acquisition. Herpes 2002, 9:10.
81. Corey L, Wald A, Patel R, et al. Once-daily valaciclovir to reduce the risk of transmission of genital herpes. New Engl J Med 2004, 350:11.
82. Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003, 289:203.
83. Randolph AG, Washington AE, Prober CG Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs. JAMA 1993, 270:77.
84. Scott LL, Sanchez PJ, Jackson GL, et al. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996, 87:69.
85. Braig S, Luton D, Sibony O, et al. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding. Eur J Obstet Gynecol Reprod Biol 2001, 96:55.
86. Watts DH, Brown ZA, Money D, et al. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol 2003, 188:836.
87. Stanberry LR, Cunningham AL, Mindel A, et al. Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis 2000, 30:549.
88. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002, 347:1652.
89. Steiner P Zu Inokulation der Varicellen. Wien Med Wochenschr 1875, 25:306.
90. von Bakay J Über den aetiologischen Zusammenhang der Varizelllen met gewissen Fällen von Herpes zoster. Wien Klin Wochenschr 1909, 22:1323.
91. Kundratitz K Experimentelle Übertagungen von Herpes zoster auf Menschen and die Beziehungen von Herpes zoster zu Varizellen. Z Kinderheilkol 1925, 39:379.
92. Weller TH, Witton HM, Bell EJ The etiologic agents of varicella and herpes zoster. J Exp Med 1958, 108:843.
93. Straus SE, Reinhold W, Smith HA, et al. Endonuclease analysis of viral DNAs from varicella and subsequent zoster infections in the same patient. N Engl J Med 1984, 311:1362.
94. Davison AJ, Scott J The complete DNA sequence of varicella-zoster virus. J Gen Virol 1986, 67:1759.
95. Davison AJ, Wilkie NM Location and orientation of homologous sequences in the genomes of five herpesviruses. J Gen Virol 1983, 64:1927.
96. Grose C Glycoproteins of varicella-zoster virus and their herpes simplex virus homologs. Rev Infect Dis 1991, 13:S960.
97. Hope-Simpson RE Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps). Lancet 1952, 2:549.
98. Sinha DP Chickenpox-A disease predominantly affecting adults in rural West Bengal, India. Int J Epidemiol 1976, 5:367.
99. Ooi PL, Goh KT, Doraisingham S, et al. Prevalence of varicella-zoster virus infection in Singapore. Southeast Asian J Trop Med Public Health 1992, 23:22.
100. Arvin AM, Koropchak CM, Wittek AM Immunologic evidence for reinfection with varicella-zoster virus. J Infect Dis 1983, 148:200.
101. Junker AK, Angus E, Thomas EE Recurrent varicella-zoster virus infections in apparently immunocompetent children. Pediatr Infect Dis J 1991, 10:569.
102. Finger R, Hughes JP, Meade BJ, et al. Age-specific incidence of chickenpox. Public Health Rep 1994, 109:750.
103. Struewing JP, Hyams KC, Tueller JE, et al. The risk of measles, mumps and varicella among young adults: A serosurvey of U.S. Navy and Marine Corps recruits. Am J Public Health 1993, 83:1717.
104. Johnson R, Milbourne PE Central nervous system manifestations of chickenpox. Can Med Assoc J 1970, 102:831.
105. Feldman S, Hughes WT, Daniel CB Varicella in children with cancer. Pediatrics 1975, 56:388.
106. van Loon F, Markowitz L, McQuillan G, et al: Varicella seroprevalence in U.S. population. In Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 1993.
107. Paryani SG, Arvin AM Intrauterine infection with varicella zoster virus after maternal varicella. N Engl J Med 1986, 314:1542.
108. Harger JH, Ernest JM, Thurnau GR, et al. Frequency of congenital varicella syndrome in a prospective cohort of 347 pregnant women. Obstet Gynecol 2002, 100:260.
109. Preblud SR, Bregman DJ, Vernon LL Deaths from varicella in infants. Pediatr Infect Dis 1985, 4:503.
110. Brunell PA Placental transfer of varicella-zoster antibody. Pediatrics 1966, 38:1034.
111. Schmader K, George LK, Burchett BM, et al. Racial differences in the occurrence of herpes zoster. J Infect Dis 1995, 171:701.
112. Berger R, Florent G, Just M Decrease of the lymphoproliferative response to varicella zoster virus antigen in the aged. Infect Immun 1981, 32:24.
113. Levin MJ, Smith JG, Kaufhold RM, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-hose VZV vaccine. J Infect Dis 2003, 188:1336.
114. Gershon AA, LaRussa P, Steinberg S, et al. The protective effect of immunologic boosting against zoster: An analysis in leukemic children who were vaccinated against chickenpox. J Infect Dis 1996, 173:450.
115. Kleinschmidt-DeMasters BK, Amlie-Lefond C, et al. The patterns of varicella-zoster virus encephalitis. Hum Pathol 1996, 27:927.
116. Sexton CJ, Navsaria HA, Leigh IM, et al. Replication of varicella-zoster virus in primary human keratinocytes. J Med Virol 1992, 38:260.
117. Weller TH Serial propagation in vitro of agents producing inclusion bodies derived from varicella and herpes zoster. Proc Soc Exp Biol Med 1953, 83:340.
118. Croen KD, Ostrove JM, Dragovic LJ, et al. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci USA 1988, 85:9773.
119. Vafai A, Wroblewska Z, Mahalingham R, et al. Recognition of similar epitopes on varicella-zoster virus gpl and gpIV by monoclonal antibodies. J Virol 1988, 62:2544.
120. Mahalingham R, Wellish M, Wolf W, et al. Latent varicella-zoster virus DNA in human trigeminal and thoracic ganglia. N Engl J Med 1990, 323:627.
121. Mahalingham R, Wellish MC, Dueland AN, et al. Localization of herpes simplex virus and varicella-zoster virus DNA in human ganglia. Ann Neurol 1992, 31:444.
122. Furuta Y, Takasu T, Fukuda S, et al. Detection of varicella-zoster virus DNA in human geniculate ganglia by polymerase chain reaction. J Infect Dis 1992, 166:1157.
123. Liedtke W, Opalka B, Zimmermann CW, et al. Age distribution of latent herpes simplex virus I and varicella-zoster virus genome in human nervous tissue. J Neurol Sci 1993, 116:6.
124. Meier JL, Holman RP, Croen KD, et al. Varicella-zoster virus transcription in human trigeminal ganglia. Virology 1993, 193:193.
125. Kennedy PG Key issues in varicella-zoster virus latency. J Neurovirol 2002, 8(Suppl 2):80.
126. Kennedy PG Varicella-zoster virus latency in human ganglia. Rev Med Virol 2002, 12:327.
127. Gilden DH, Cohrs RJ, Mahalingam R Clinical and molecular pathogenesis of varicella virus infection. Viral Immunol 2003, 16:243.
128. Stocher M, Leb V, Bozic M, et al. Parallel detection of five human herpes virus DNAs by a set of real-time polymerase chain reactions in a single run. J Clin Virol 2003, 26:85.
129. Arvin AM Antiviral therapy for varicella and herpes zoster. Semin Pediatr Infect Dis 2002, 13:12.
130. Shepp D, Dandliker PS, Meyers JD Treatment of varicella-zoster virus in severely immunocompromised patients: A randomized comparison of acyclovir and vidarabine. N Engl J Med 1987, 314:208.
131. Balfour HH, Rotbart HA, Feldman S, et al. Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr 1992, 120:627.
132. Dunkle LM, Arvin AM, Whitley RJ, et al. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med 1991, 325:1539.
133. Enright AM, Prober C Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections. Herpes 2003, 10:32.
134. Klassen TP, Belseck EM, Wiebe N, et al. Acyclovir for treating varicella in otherwise healthy children and adolescents: a systematic review of randomised controlled trials. BMC Pediatr 2002, 2:9.
135. Jacobson MA, Berger TG, Fikrig S, et al. Acyclovir-resistant varicella-zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990, 112:187.
136. Gershon AA Prevention and treatment of VZV infections in patients with. HIV Herpes 2001, 8:32.
137. Johnson RW, Dworkin RH Treatment of herpes zoster and postherpetic neuralgia. BMJ 2003, 26:748.
138. Curran MP, Wagstaff AJ Gabapentin: in postherpetic neuralgia. CNS Drugs 2003, 17:975.
139. Arvin AM, Gershon AA Live attenuated varicella vaccine. Annu Rev Microbiol 1996, 50:59.
140. Decline in annual incidence of varicella-Selected states, 1990-2001. MMWR 2003, 52:884. Centers for Disease Control and Prevention (CDC).
141. Plotkin SA, Starr SE, Connor K, et al. Zoster in normal children after varicella vaccine. J Infect Dis 1989, 159:1000.
142. Watson BM, Piercy SA, Plotkin SA, et al. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 1993, 91:17.
143. Gershon AA, Steinger SP, LaRussa P, et al. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis 1988, 158:132.
144. Galil K, Lee B, Strine T, et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 2002, 347:1909.
145. Gershon AA Symposium on infectious complications of neoplastic disease (Part II). Immunoprophylaxis of varicella-zoster infections. Am J Med 1984, 76:672.
146. Roizman B, Carmichael LE, Deinhardt F, et al. Herpesviridae. Definition, provisional nomenclature, and taxonomy. Intervirology 1981, 16:201.
147. Karlin S, Mocarski ES, Schachtel GA Molecular evolution of herpesviruses: Genomic and protein sequence comparisons. J Virol 1994, 68:1886.
148. Wright HT, Goodheart CR, Lielausis A Human cytomegalovirus. Morphology by negative staining. Virology 1964, 23:419.
149. Geelen JL, Walig C, Wertheim P, et al. Human cytomegalovirus DNA. I. Molecular weight and infectivity. J Virol 1978, 26:813.
150. Lakeman AD, Osborn JE Size of infectious DNA from human and murine cytomegaloviruses. J Virol 1979, 30:414.
151. Chee MS, Bankier AT, Beck S, et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus stain AD169. Curr Top Microbiol Immunol 1990, 154:125.
152. Kim KS, Sapienza VJ, Carp RI, et al. Analysis of structural polypeptides of purified human cytomegalovirus. J Virol 1976, 20:604.
153. Jahn G, Mach M Human cytomegalovirus phosphoproteins and glycoproteins and their coding regions. Curr Top Microbiol Immunol 1990, 154:171.
154. Gibson W Protein counterparts of human and simian cytomegaloviruses. Virology 1983, 128:391.
155. Rasmussen L, Resta S, Merigan T Human cytomegalovirus glycoprotein-receptor interactions. Transplant Proc 1991, 23:60.
156. Borysiewicz LK, Hickling JK, Graham S, et al. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia virus. J Exp Med 1988, 168:919.
157. Chou S Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirus. Virology 1992, 188:388.
158. Fries BC, Chou S, Boeckh M, et al. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 1994, 169:769.
159. Gold E, Nankervis GA Cytomegalovirus. Viral Infections of Humans: Epidemiology and Control 1982, 167. Plenum Press, New York. 2nd ed. A.S. Evans (Ed.).
160. Kumar ML, Nankervis GA, Gold E Inapparent congenital cytomegalovirus infection: A follow-up study. N Engl J Med 1973, 288:1377.
161. Alford CA, Stagno S, Pass RF, et al. Epidemiology of cytomegalovirus. The Human Herpesviruses: An Interdisciplinary Perspective 1981, 159. Elsevier, New York. A. Nahmais, W. Dowdle, R. Schinazi (Eds.).
162. Reynolds DW, Stagno S, Hosty TS, et al. Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med 1973, 289:1.
163. Stagno S, Reynolds DW, Pass RF, et al. Breast milk and the risk of cytomegalovirus infection. N Engl J Med 1980, 302:1073.
164. Dworsky M, Yow M, Stagno S, et al. Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics 1983, 72:295.
165. Pass RF, Hutto C, Reynolds DW, et al. Increased frequency of cytomegalovirus in children in group day care. Pediatrics 1984, 74:121.
166. Horwitz CA, Henle W, Henle G Diagnostic aspects of the cytomegalovirus mononucleosis syndrome in previously healthy persons. Postgrad Med 1979, 66:153.
167. Klemola E, Kaariainen L Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. BMJ 1965, 2:1099.
168. Sun A, Chang JG, Kao CL, et al. Human cytomegalovirus as a potential etiologic agent in recurrent aphthous ulcers and Behçet's disease. J Oral Pathol Med 1996, 25:212.
169. Boppana SB, Pass RF, Britt WJ, et al. Symptomatic congenital cytomegalovirus infection: Neonatal morbidity and mortality. Pediatr Infect Dis 1992, 11:93.
170. Hicks T, Fowler K, Richardson M, et al. Congenital cytomegalovirus infections and neonatal auditory screening. J Pediatr 1993, 123:779.
171. Stagno S, Reynolds DW, Tsiantos A, et al. Comparative, serial virologic and serologic studies of symptomatic and subclinical congenital and naturally acquired cytomegalovirus infection. J Infect Dis 1975, 132:568.
172. Pollard AB Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation. Pediatr Infect Dis J 1988, 7:97.
173. Lautenschlager I, Hockerstedt K, Jalanko H, et al. Persistent cytomegalovirus in liver allografts with chronic rejection. Hepatology 1997, 25:190.
174. Boriskin YS, Booth JC, Corbishley CM, et al. Human cytomegalovirus and acute rejection after heart transplantation are not directly associated. J Med Virol 1996, 50:59.
175. Persson L, Dahl H, Linde A, et al. Human cytomegalovirus, human herpesvirus-6 and human herpesvirus-7 in neutropenic patients with fever of unknown origin. Clin Microbiol Infect 2003, 9:640.
176. Webster A Cytomegalovirus as a possible cofactor in HIV disease progression. J Acquir Immune Defic Syndr Hum Retrovirol 1991, 4:S47.
177. Shi Y, Tokunaga O Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int 2002, 52:31.
178. Lin TM, Chen WJ, Chen HY, et al. Increased incidence of cytomegalovirus but not Chlamydia pneumoniae in atherosclerotic lesions of arteries of lower extremities from patients with diabetes mellitus undergoing amputation. J Clin Pathol 2003, 56:429.
179. Stinski MF Molecular biology of cytomegaloviruses. The Herpesviruses 1983, 67. Plenum Press, New York. B. Roizman (Ed.).
180. Rowe WP, Hartley JW, Waterman S, et al. Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc Soc Exp Biol Med 1956, 92:418.
181. Tanaka S, Furukawa T, Plotkin SA Human cytomegalovirus simulates host cell RNA synthesis. J Virol 1975, 15:297.
182. Furukawa T, Sakuma S, Plotkin SA Human cytomegalovirus infection of WI-38 cells stimulates mitochondrial DNA synthesis. Nature 1976, 262:414.
183. Fons MP, Graves K, Cavallo T, et al. Human cytomegalovirus: Development and progression of nuclear inclusions by primary clinical isolates and laboratory-adapted stains. Proc Soc Exp Biol Med 1986, 181:416.
184. Fetterman GH, Sherman FE, Fabizio NS, et al. Generalized cytomegalic inclusion disease of the newborn: Localization of inclusions in the kidney. Arch Pathol 1968, 86:86.
185. Myerson D, Hackman RC, Nelson JA, et al. Widespread presence of histologically occult cytomegalovirus. Hum Pathol 1984, 15:430.
186. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, et al. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991, 72:2059.
187. Taylor-Wiedeman J, Hayhurst GP, Sissons JG, et al. Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J Gen Virol 1993, 74:265.
188. Weber B, Opp M, Born HJ, et al. Laboratory diagnosis of congenital human cytomegalovirus infection using polymerase chain reaction and shell vial culture. Infection 1992, 20:155.
189. Carter IW, Cloonan MJ Comparison between three PCR methods for detection of human cytomegalovirus DNA. Pathology 1995, 27:161.
190. Barber L, Egan JJ, Lomax J, et al. Comparative study of three PCR assays with antigenaemia and serology for the diagnosis of HCMV infection in thoracic transplant recipients. J Med Virol 1996, 49:137.
191. Vogelberg C, Meyer-Konig U, Hufert FT, et al. Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients. J Med Virol 1996, 50:31.
192. Lurain NS, Thompson KD, Holmes EW, et al. Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. J Virol 1992, 66:7146.
193. Stanat SC, Reardon JE, Eric A, et al. Ganciclovir-resistant cytomegalovirus clinical isolates: Mode of resistance to ganciclovir. Antimicrob Agents Chemother 1991, 35:2191.
194. Sullivan V, Biron KK, Talarico C, et al. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives. Antimicrob Agents Chemother 1993, 37:19.
195. Chou S, Lurain NS, Thompson KD, et al. Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. J Infect Dis 2003, 188:32.
196. Adler SP, Finney JW, Manganello AM, et al. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: A randomized controlled trial. Pediatr Infect Dis J 1996, 15:240.
197. Britt WJ Vaccines against human cytomegalovirus: Time to test. Trends Microbiol 1996, 4:34.
198. Kieff E Epstein-Barr virus and its replication. Fields' Virology 1996, 2343. Lippincott-Raven, Philadelphia. 3rd ed. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
199. Epstein MA, Achong BG, Barr YM Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964, 1:7203.
200. Henle W, Diehl V, Kohn G, et al. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 1967, 157:1064.
201. Pope JH, Achong BG, Epstein MA Burkitt lymphoma in New Guinea: Establishment of a line of lymphoblasts in vitro and description of their fine structure. J Natl Cancer Inst 1967, 39:933.
202. Henle G, Henle W, Hiehl V Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 1968, 59:94.
203. Zur Hausen H, Schule-Holthausen H, Klein G, et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 1970, 228:1056.
204. Wolf H, zur Hasen H, Becker V EBV viral genomes in epithelial nasopharyngeal carcinoma cells. Nature 1973, 244:245.
205. Nonoyama M, Huang CH, Pagano JS, et al. DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci USA 1973, 70:3265.
206. Greenspan JS, Greenspan D, Lennette ET, et al. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med 1985, 313:1564.
207. Weiss LM, Strickler JG, Warnke RA, et al. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 1987, 129:86.
208. Weiss LM, Movahed LA, Butler AE, et al. Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr virus by in situ hybridization. Am J Surg Pathol 1989, 13:625.
209. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990, 335:128.
210. Su IJ, Hsieh HC, Lin KH, et al. Aggressive peripheral T-cell lymphoma containing Epstein-Barr viral DNA: A clinicopathological and molecular analysis. Blood 1991, 68:1954.
211. Fingeroth JD, Weiss JJ, Teddr TF, et al. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 1984, 81:45610.
212. Baer R, Bankier AT, Biggin MD, et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984, 310:207.
213. Pearson G, Luka J, Petti L, et al. Identification of an Epstein-Barr virus early gene encoding for a second component of the restricted early antigen complex. Virology 1987, 160:151.
214. Moore KW, Vieira P, Fiorentino DF, et al. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990, 248:1230.
215. Packham G, Economou A, Rooney CM, et al. Structure and function of the Epstein-Barr virus BZLF1 protein. J Virol 1990, 64:2110.
216. Sixbey JW, Shirley P, Chesney PJ, et al. Detection of a second widespread strain of Epstein-Barr virus. Lancet 1989, 2:761.
217. Apolloni A, Sculley TB Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes. Virology 1994, 202:978.
218. Rickinson AB, Young LS, Rowe M Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 1987, 61:1310.
219. Hudnall SD, Patel J, Schwab H, et al. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis. Clin Cytometry 2003, 55B:22-28.
220. Shibata D, Weiss LM Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992, 140:769.
221. Imai S, Koizumi S, Sugiura M, et al. Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 1994, 91:9131.
222. Kingma DW, Shad A, Tsokos M, et al. Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Case report. Am J Surg Pathol 1996, 20:1511.
223. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 1995, 332:12.
224. Anagnostopoulos I, Hummel M Epstein-Barr virus in tumours. Histopathology 1996, 29:297.
225. Purtilo DT, Cassel C, Yang JSP, et al. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1975, 1:935.
226. Burkitt D A children's cancer dependent upon climatic factors. Nature 1962, 194:232.
227. Andersson M, Klein G, Zigler JL, et al. Association of Epstein-Barr viral genomes with American Burkitt lymphoma. Nature 1976, 260:357.
228. Shiramizu B, Barriga F, Neequaye J, et al. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: Relevant to geography and EBV association. Blood 1991, 77:1516.
229. Chan SH, Day NE, Kunaratnam N, et al. HLA and nasopharyngeal carcinoma in Chinese-A further study. Int J Cancer 1983, 32:171.
230. Yu MC, Ho JHC, Lai SH, et al. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: Report of a case-control study in Hong Kong. Cancer Res 1986, 46:956.
231. Yu MC, Huang TB, Henderson BE Diet and nasopharyngeal carcinoma: A case-control study in Guangzhou, China. Int J Cancer 1989, 43:1077.
232. Armstrong RW, Armstrong MJ, Jay MC, et al. Salted fish and inhalants as risk factors for carcinoma in Malaysian Chinese. Cancer Res 1983, 43:2697.
233. West S, Hildesheim A, Dosemeci M Non-viral risk factors for nasopharyngeal carcinoma in the Philippines: Result from a case-control study. Int J Cancer 1993, 55:722.
234. Poirier S, Ohshiima H, de The G, et al. Volatile nitrosamine levels in common foods from Tunisia, South China and Greenland, high risk areas for nasopharyngeal carcinoma (NPC). Int J Cancer 1987, 39:293.
235. Levine PH, Conelly R Epidemiology of nasopharyngeal cancer. Head and Neck Cancer 1985, 13. Wiley, New York. R.E. Wittes (Ed.).
236. Niedobitek G, Hansmann ML, Herbst H, et al. Esptein-Barr virus and carcinomas: Undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991, 165:17.
237. Young LS, Dawson CW, Clark D, et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988, 69:1051.
238. Wang D, Liebowitz D, Kieff E The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. J Virol 1988, 62:2337.
239. Wang F, Gregory CD, Rowe M, et al. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci USA 1987, 83:3452.
240. Dawson CW, Rickinson AB, Young LS Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 1990, 344:777.
241. Niedobitek G, Herbst H, Young LS, et al. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 1992, 79:2520.
242. Choi PHK, Seven MWM, Haung DP, et al. Nasopharyngeal carcinoma: Genetic changes, Epstein-Barr virus infection, or both. A clinical and molecular study of 36 patients. Cancer 1993, 72:2873.
243. Niedobitek G, Rowlands DC, Young LS, et al. Overexpression of p53 in Hodgkin's disease: Lack of correlation with Epstein-Barr virus infection. J Pathol 1993, 169:207.
244. Lu QL, Elia G, Lucas S, et al. Bcl-2 proto-oncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int J Cancer 1993, 53:29.
245. Starzl TE, Penn I, Halgrimson CG Immunosuppression and malignant neoplasms. N Engl J Med 1970, 283:934.
246. Penn I Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet 1986, 162:603.
247. Swinnen LJ Lymphoproliferative disorders following organ transplantation: Clinical syndromes and treatment options. EBV Rep 1996, 3:141.
248. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988, 45:719.
249. Walker RC, Paya CV, Marshall WF, et al. Pretransplantation seronegative Eptein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantation. J Heart Lung Transplant 1995, 14:214.
250. Morrison VA, Dunn DL, Manivel JC, et al. Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 1994, 97:14.
251. Cleary ML, Warnke R, Sklar J Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements. N Engl J Med 1984, 310:488.
252. Hanto DW, Birkenbach M, Frizzera G, et al. Confirmation of the heterogeneity of posttransplant Epstein-Barr virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses. Transplantation 1989, 47:458.
253. Katz BZ, Raab-Traub N, Miller G Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative disease. J Infect Dis 1989, 160:589.
254. Locker J, Nalesnik M Molecular genetic analysis of lymphoid tumours arising after organ transplantation. Am J Pathol 1989, 235:977.
255. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post-transplantation lymphoproliferative disorders. Blood 1995, 85:552.
256. Hodgkin T On some morbid appearance of the absorbent glands and spleen. Med Chir Trans 1832, 17:68.
257. Gutensohn N, Cole P Epidemiology of Hodgkin's disease. Semin Oncol 1980, 7:92.
258. Carbone P, Kaplan H, Musshoff K, et al. Report of the committee on Hodgkin's disease staging. Cancer Res 1971, 31:1860.
259. Lukes R, Craver L, Hall T, et al. Report of the nomenclature committee. Cancer Res 1966, 26:1311.
260. Trumper LH, Brady G, Bragg A, et al. Single-cell analysis of Hodgkin and Reed-Sternberg cells: Molecular heterogeneity of gene expression and p53 mutations. Blood 1993, 81:3097.
261. Roth G, Curiel T, Lacy J Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells. Blood 1994, 84:582.
262. Kupper R, Rajewsky K, Zhao M, et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 1994, 91:10962.
263. Niedobitek G The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease. Ann Oncol 1996, 4:S11.
264. Anagnostopouos I, Herbst H, Niedobitek G, et al. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989, 74:810.
265. Knecht H, Brousset P, Bachmann E, et al. Latent membrane protein 1: A key oncogene in EBV-related carcinogenesis?. Acta Haematol 1993, 90:167.
266. Sandvej K, Munch M, Hamilton-Dutoit S Mutations in the Epstein-Barr virus latent membrane protein-1 (BNLF-1) gene in spontaneous lymphoblastoid cell lines-Effect on in vitro transformation associated parameters and tumorigenicity in scid and nude mice. JCP Clin Mol Pathol 1996, 49:290.
267. Hummel M, Anagnostopoulos I, Dallengach F, et al. EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: Expression and cellular localization of EBV gene products. Br J Haematol 1992, 82:689.
268. Jarrett RF, Gallagher A, Jones DB, et al. Detection of Epstein-Barr virus genomes in Hodgkin's disease: Relation to age. J Clin Pathol 1991, 44:844.
269. Khan G, Norton AJ, Slavin G Epstein-Barr virus in Hodgkin disease. Relation to age and subtype. Cancer 1993, 71:3124.
270. Ambinder RF, Browning PJ, Loren ZI, et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993, 81:462.
271. Jarrett AF, Armstrong AA, Alexander E Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol 1996, 7:5.
272. Lin AY, Kingma DW, Lennette ET, et al. Epstein-Barr virus and familial Hodgkin's disease. Blood 1996, 88:3160.
273. Miller G, Lipman M Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 1973, 70:190.
274. Mueller NE Epstein-Barr virus and Hodgkin's disease: An epidemiological paradox. EBV 1997, 4:1.
275. Frisan T, Sjoberg J, Dolcetti R, et al. Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 1995, 86:1493.
276. Popperma S, Kaleta J, Hepperle B Chromosomal abnormalities in patients with Hodgkin's disease: Evidence for frequent involvement of the 14q chromosomal region but infrequent bcl-2 gene rearrangement in Reed-Sternberg cells. J Natl Cancer Inst 1992, 84:1789.
277. Fellbaum C, Hansmann ML, Niedermeyer H, et al. Influence of Epstein-Barr virus genomes on patient survival in Hodgkin's disease. Am J Clin Pathol 1992, 98:319.
278. Su IJ Epstein-Barr virus and T cell lymphomas. EBV Rep 1996, 3:1.
279. Su IJ, Hsieh HC, Lin KH, et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysis. Blood 1991, 77:799.
280. Anagnostopoulos I, Hummel M, Finn T, et al. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1992, 80:1804.
281. Kanavaros P, Jiwa NM, de Bruin PC, et al. High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas. J Pathol 1992, 168:307.
282. Su IJ, Hsu YH, Liu MT, et al. Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 1993, 72:2019.
283. Ishihara S, Ohshima K, Tokura Y, et al. Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Jpn J Cancer Res 1997, 88:82.
284. Yachie A, Kanegane H, Kasahara Y Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases. Semin Hematol 2003, 40:124.
285. Rowe M, Lear AL, Croom Carter D, et al. Three pathways of Epstein-Barr virus gene activation from EBNA1 positive latency in B lymphocytes. J Virol 1992, 66:122.
286. Wang D, Liebowitz D, Kieff E An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985, 43:831.
287. Dalla Favera R, Martinotti S, Gallo RC, et al. Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 1983, 219:963.
288. Marcu KB, Harris LJ, Stantnon LW, et al. Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia. Proc Natl Acad Sci USA 1983, 80:519.
289. Polack A, Hortnagel K, Pajic A, et al. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1. Proc Natl Acad Sci USA 1996, 93:10411.
290. Raab-Traub N, Flynn K The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986, 47:883.
291. Gilligan K, Rajadurai P, Lin JC, et al. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: Evidence for a viral protein expressed in vivo. J Virol 1991, 65:6252.
292. Pallesen G, Hamilton-Dutoit SJ, Rowe M, et al. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991, 337:320.
293. Yip TC, Lau WH, Ngan RKC, et al. Role of Epstein-Barr virus serology in the present and the future. EBV Rep 1996, 3:25.
294. Riddler SA, Breinig MC, McKnight JLC Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of post-transplant lymphoproliferative disease in solid-organ transplant recipients. Blood 1994, 84:972.
295. Savoie A, Perpete C, Carpentier L, et al. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 1994, 83:2715.
296. Rooney CM, Loftin SK, Holladay MS, et al. Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematol 1995, 89:98.
297. Ho JHC Nasopharynx. Treatment of Cancer 1982, 249. Chapman & Hall, London. K.E. Halnan, J.L. Boak, D. Crowther (Eds.).
298. Huang SC, Chu GL Nasopharyngeal cancer: Study II. Int J Radiat Oncol Biol Phys 1981, 7:713.
299. Chan ATC, Teo PML, Leung TWT, et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1995, 33:569.
300. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin A-steroid therapy. Lancet 1984, 1:583.
301. Shapiro RS, Chauvenet A, McGuire W, et al. Treatment of B-cell lymphoproliferative disorders with interferon alpha and intravenous gamma globulin. N Engl J Med 1988, 318:1334.
302. Filipovich AH, Mathur A, Kamat D, et al. Lymphoproliferative disorders and other tumors complicating immunodeficiencies. Immunodeficiency 1994, 5:91.
303. Leblond V, Sutton L, Dorent R, et al. Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single center. J Clin Oncol 1995, 13:961.
304. Papadopoulos EB, Ladanyi M, Emanuel D, et al. Infusion of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994, 330:1185.
305. Rooney CM, Smith CA, Breener MK, et al. Prophylaxis and treatment of Epstein-Barr virus lymphoproliferative disease using genetically modified cytotoxic T lymphocytes. Lancet 1995, 345:9.
306. Resnick L, Herbst JS, Ablashi DV, et al. Regression of oral hairy leukoplakia after orally administered acyclovir therapy. JAMA 1988, 259:384.
307. Greenspan D, DeSouza YG, Conant MA, et al. Efficacy of desciclovir in the treatment of Epstein-Barr virus infection in oral hairy leukoplakia. AIDS 1990, 3:571.
308. Ishii M, Yamaguchi N, Ohshima S, et al. Possibility of preventive treatment for EBV-associated NK cell-lineage proliferative disorders. Intern Med 2003, 42:250.
309. Thorley-Lawson DA, Geilinger K Monoclonal antibodies against the major glycoprotein (gp 350/220) of Epstein-Barr virus neutralize infectivity. Proc Natl Acad Sci USA 1980, 77:5308.
310. Morgan AJ Epstein-Barr virus vaccines. Vaccine 1992, 10:563.
311. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986, 243:596.
312. Downing RG, Sewankambo N, Serwadda D, et al. Isolation of human lymphotropic herpesviruses from Uganda. Lancet 1987, 2:390.
313. Lopez C, Pellett P, Stewart J, et al. Characteristics of human herpes virus-6. J Infect Dis 1988, 157:1271.
314. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988, 1:1065.
315. Biberfeld P, Kramarsky B, Salahuddin SZ, et al. Ultrastructural characterization of a new human B lymphotropic DNA virus (HBLV) isolated from patients with lymphoproliferative disease. J Natl Cancer Inst 1987, 79:933.
316. Wyatt LS, Balachandran N, Frenkel N Variations in the replication and antigenic properties of human herpesvirus 6 strains. J Infect Dis 1990, 162:852.
317. Ablashi DV, Lusso P, Hung C Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). Int J Cancer 1988, 42:787.
318. Ablashi DV, Lusso P, Hung C, et al. Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). Dev Biol Stand 1989, 70:139.
319. Black JB, Sanderlin KC, Goldsmith CS, et al. Growth properties of human herpesvirus-6 strain Z29. J Virol Methods 1989, 26:133.
320. Luka J, Okano M, Thiele G Isolation of human herpesvirus-6 from clinical specimens using human fibroblast cultures. J Clin Lab Anal 1990, 4:483.
321. Takahashi K, Sonoda S, Higashi K, et al. Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol 1989, 63:3161.
322. Higashi K, Asada H, Kurata T, et al. Presence of antibody to human herpesvirus 6 in monkeys. J Gen Virol 1989, 70:3171.
323. Lusso P, Markham PD, DeRocco SE, et al. In vitro susceptibility of T lymphocytes from chimpanzees ( Pantroglodytes) to human herpes virus 6 (HHV-6): A potential animal model to study the interaction between HHV-6 and human immunodeficiency virus type 1 in vivo. J Virol 1990, 64:2751.
324. Martin MED, Thomas BJ, Honess RW, et al. The genomes of human herpesvirus 6: Maps of unit-length and concatemeric genomes for nine restriction endonucleases. J Gen Virol 1991, 72:157.
325. Lindquester GJ, Pellett PE Properties of the human herpesvirus 6 strain Z29 genome: G + C content, length, and presence of variable-length directly repeated terminal sequence elements. Virology 1991, 182:102.
326. Neipel F, Ellinger K, Fleckenstein B The unique region of the human herpesvirus 6 genome is essentially collinear with the UL segment of human cytomegalovirus. J Gen Virol 1991, 72:2293.
327. Lawrence GL, Chee M, Craxton MA, et al. Human herpesvirus 6 is closely related to human cytomegalovirus. J Virol 1990, 64:297.
328. Ablashi DV, Balachandran N, Josephs SF, et al. Genomic polymorphism, growth properties and immunologic variations in human herpesvirus-6 isolates. Virology 1991, 184:545.
329. Pellett PE, Black JB, Yamamoto M Human herpesviruses 6: The virus and the search for its role as a human pathogen. Virology 1992, 41:1.
330. Thomson BJ, Efstathiou S, Honess RW Acquisition of the human adeno-associated virus type-2 rep gene by human herpesvirus type-6. Nature 1991, 351:78.
331. Razzaque A Oncogenic potential of human herpesvirus-6 DNA. Oncogene 1990, 5:1365.
332. Kempe CH, Shaw EB, Jackson JR, et al. Studies on the etiology of exanthema subitum (roseola infantum). J Pediatr 1950, 37:561.
333. Aubin J, Collandre H, Candotti D, et al. Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J Clin Microbiol 1991, 29:367.
334. Dewhurst S, Chandran B, McIntyre K, et al. Phenotypic and genetic polymorphisms among human herpesvirus-6 isolates from North American infants. Virology 1992, 190:490.
335. Saxinger C, Polesky H, Eby N, et al. Antibody reactivity with HBLV (HHV-6) in U.S. populations. J Virol Methods 1988, 21:199.
336. Tanaka-Taya K, Kondo T, Mukai T, et al. Seroepidemiological study of human herpesvirus-6 and -7 in children of different ages and detection of these two viruses in throat swabs by polymerase chain reaction. J Med Virol 1996, 48:88.
337. Cermelli C, Fabio G, Montorsi M, et al. Prevalence of antibodies to human herpesviruses 6 and 7 in early infancy and age at primary infection. New Microbiol 1996, 19:1.
338. Kositanont U, Wasi C, Ekpatcha N, et al. Seroprevalence of human herpesvirus 6 and 7 infections in the Thai population. Asian Pac J Allergy Immunol 1995, 13:151.
339. Krueger GRF, Wassermann K, de Clerck LS, et al. Latent herpesvirus-6 in salivary and bronchial glands. Lancet 1990, 336:1255.
340. Fox JD, Briggs M, Ward PA, et al. Human herpesvirus 6 in salivary glands. Lancet 1990, 336:590.
341. Sada E, Yasukawa M, Ito C, et al. Detection of human herpesvirus 6 and human herpesvirus 7 in the submandibular gland, and lip salivary gland by PCR. J Clin Microbiol 1996, 34:2320.
342. DiLuca D, Mirandola P, Ravaioli T, et al. Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol 1995, 45:462.
343. Harnett GB, Farr TJ, Pietroboni GR, et al. Frequent shedding of human herpes virus 6 in saliva. J Med Virol 1990, 30:128.
344. Levy JA, Ferro F, Lennette ET, et al. Characterization of a new strain of HHV-6 (HHV-6SF) recovered from the saliva of an HIV-infected individual. Virology 1990, 178:113.
345. Wyatt LS, Frenkel N Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol 1992, 66:3206.
346. Hidaka Y, Liu Y, Yamamoto M, et al. Frequent isolation of human herpesvirus 7 from saliva samples. J Med Virol 1993, 40:343.
347. Black JB, Inoue N, Kite-Powell K, et al. Frequent isolation of human herpesvirus 7 from saliva. Virus Res 1993, 29:91.
348. Okuno T, Oishi H, Hayashi K, et al. Human herpesviruses 6 and 7 in cervixes of pregnant women. J Clin Microbiol 1995, 33:1968.
349. Byington CL, Zerr DM, Taggart EW, et al. Human herpesvirus 6 infection in febrile infants ninety days of age or younger. Pediatr Infect Dis J 2002, 21:996.
350. Oliveira SA, Turner DJ, Knowles W, et al. Primary human herpesvirus-6 and -7 infections, often coinciding, misdiagnosed as measles in children from a tropical region of Brazil. Epidemiol Infect 2003, 131:873.
351. Levine PH Applications of experimental techniques to epidemiological studies of non-Hodgkin's lymphoma: Use of archival tissues. Cancer Res 1992, 52:5561.
352. Dubedat S, Kappagoda N Hepatitis due to human herpes virus-6. Lancet 1989, 2:146.
353. Steeper TA, Horwitz CA, Ablashi DV, et al. The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol 1990, 93:776.
354. Gold D, Bowden R, Sixbey J, et al. Chronic fatigue. A prospective clinical and virologic study. JAMA 1990, 264:48.
355. Harma M, Hockerstedt K, Lautenschlager I Human herpesvirus-6 and acute liver failure. Transplantation 2003, 76:536.
356. Jarrett RF, Gledhill S, Qureshi F, et al. Identification of human herpes virus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia 1988, 2:496.
357. Josephs SF, Buchbinder A, Streicher HZ, et al. Detection of human B-lymphotropic virus (human herpes virus 6) sequences in B cell lymphoma tissues of three patients. Leukemia 1988, 2:132.
358. Torelli G, Marasca R, Luppi M, et al. Human herpesvirus-6 in human lymphomas: Identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction. Blood 1991, 77:2251.
359. Goodman AD, Mock DJ, Powers JM, et al. Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J Infect Dis 2003, 187:1365.
360. Cermelli C, Berti R, Soldan SS, et al. High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis 2003, 187:1377.
361. Secchiero P, Zella D, Crowley RW, et al. Quantitative PCR for human herpesviruses 6 and 7. J Clin Microbiol 1995, 33:2124.
362. Frenkel N, Schirmer EC, Wyatt LS, et al. Isolation of new herpes virus from CD4+ T cells. Proc Natl Acad Sci USA 1990, 89:748.
363. Frenkel N, Wyatt LS HHV-6 and HHV-7 as exogenous agents in human lymphocytes. Dev Biol Stand 1992, 76:259.
364. Berneman ZN, Ablashi DV, Li G, et al. Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci USA 1992, 89:10552.
365. Nicholas J Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J Virol 1996, 70:5975.
366. Ruvolo VR, Berneman Z, Secchiero P, et al. Cloning, restriction endonuclease mapping and partial sequence analysis of the genome of human herpesvirus 7 strain JI. J Gen Virol 1996, 77:1901.
367. Wyatt LS, Rodriguez WJ, Balachandran N, et al. Human herpesvirus 7: Antigenic properties and prevalence in children and adults. J Virol 1991, 65:6260.
368. Foa-Tomasi L, Avitabile E, Ke L, et al. Polyvalent and monoclonal antibodies identify major immunogenic proteins specific for human herpesvirus 7-infected cells and have weak cross-reactivity with human herpesvirus 6. J Gen Virol 1994, 75:2719.
369. Yasukawa M, Yakushijin Y, Furukawa M, et al. Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. J Virol 1993, 67:6259.
370. Yoshikawa T, Asano Y, Kobayashi I, et al. Seroepidemiology of human herpesvirus 7 in healthy children and adults in Japan. J Med Virol 1993, 41:319.
371. Kidd IM, Clark DA, Ait-Khaled M, et al. Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction. J Infect Dis 1996, 174:396.
372. Clark DA, Freeland ML, Mackie LK, et al. Prevalence of antibody to human herpesvirus 7 by age. J Infect Dis 1993, 168:251.
373. Caserta MT, Hall CB, Schnabel K, et al. Primary human herpesvirus 7 infection: A comparison of human herpesvirus 7 and human herpesvirus 6 infections in children. J Pediatr 1998, 133:386.
374. Kawa-Ha K, Tanaka K, Inoue M, et al. Isolation of human herpesvirus 7 from a child with symptoms mimicking chronic Epstein-Barr virus infection. Br J Haematol 1993, 84:545.
375. Hashida T, Komura E, Yoshida M, et al. Hepatitis in association with human herpesvirus-7 infection. Pediatrics 1995, 96:783.
376. Portolani M, Cermelli C, Mirandola P, et al. Isolation of human herpesvirus 7 from an infant with febrile syndrome. J Med Virol 1995, 45:282.
377. Tanaka K, Kondo T, Torigoe S, et al. Human herpesvirus 7: Another causal agent for roseola (exanthem subitum). J Pediatr 1994, 125:1.
378. Osman HK, Peiris JS, Taylor CE, et al. "Cytomegalovirus disease" in renal allograft recipients: Is human herpesvirus 7 a co-factor for disease progression?. J Med Virol 1996, 48:295.
379. Katsafanas GC, Schirmer EC, Wyatt LS, et al. In vitro activation of human herpesviruses 6 and 7 from latency. Proc Natl Acad Sci USA 1996, 93:9788.
380. Russo JJ, Bohenzky RA, Chien MC, et al. Nucleotide sequence of the Kaposi's sarcoma associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996, 93:14862.
381. Neipel F, Albrecht JC, Ensser A, et al. Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 1997, 71:839.
382. Moore PS, Gao SJ, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 1996, 70:549.
383. Renne R, Lagunoff M, Zhong W, et al. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol 1996, 70:8151.
384. Moore PS, Boshoff C, Weiss RA, et al. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996, 274:1739.
385. Chang Y, Moore PS, Talbot SJ, et al. Cyclin encoded by KS herpesvirus. Nature 1996, 382:410.
386. Miller G, Rigsby MO, Heston L, et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 1996, 334:1292.
387. Gompels UA, Kasolo FC HHV-8 serology and Kaposi's sarcoma. Lancet 1996, 348:1587.
388. Lennette ET, Blackbourn DJ, Levy JA Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996, 348:858.
389. Hudnall SD, Chen T, Rady P, et al. Human herpesvirus 8 seroprevalence and viral load in healthy adult blood donors. Transfusion 2003, 43:85.
390. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996, 2:925.
391. Kedes DH, Operskalski E, Busch M, et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus)- Distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996, 2:918.
392. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996, 348:1133.
393. Whitby D, Howard MR, Tenantflowers M, et al. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995, 346:799.
394. Hudnall SD, Rady PL, Tyring SK, Fish JC Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients. J Infect Dis 1998, 178:1791.
395. Hudnall SD, Rady PL, Tyring SK, et al. Hydrocortisone activation of HHV8 replication and gene expression in vitro. Transplantation 1999, 67:648.
396. Blackbourn DJ, Ambroziak J, Lennette E, et al. Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 1997, 349:609.
397. Regamey N, Tamm M, Wernli M, et al. Transmission of HHV8 infection from renal transplant donors to recipients. N Engl J Med 1998, 339:1358.
398. Schulz TF Kaposi's sarcoma-associated herpes virus (human herpesvirus 8). J Gen Virol 1998, 79:1573.
399. Rabkin CS, Schulz TF, Whitby D, et al. Interassay correlation of human herpesvirus 8 serologic tests. HHV8 Interlaboratory Collaborative Group. J Infect Dis 1998, 178:304.
400. Mayama S, Cuevas LE, Sheldon J, et al. Prevalence and transmission of KSHV in Ugandan children and adolescents. Int J Cancer 1998, 77:817.
401. Blauvelt A, Sei S, Cook PM, et al. Human herpesvirus 8 infection occurs following adolescence in the United States. J Infect Dis 1997, 176:771.
402. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996, 2:342.
403. Ansari MQ, Dawson DB, Nador R, et al. Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol 1996, 105:221.
404. Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995, 332:1186.
405. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86:1276.
406. Luppi M, Barozzi P, Maiorana A, et al. Frequency and distribution of herpesvirus-like DNA sequences (KSHV) in different stages of classic Kaposi's sarcoma and in normal tissues from an Italian population. Int J Cancer 1996, 66:427.
407. Rady PL, Yen A, Rollefson JL, et al. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 1995, 345:1339.
408. McDonagh DP, Liu J, Gaffey MJ, et al. Detection of Kaposi's sarcoma-associated herpesvirus-like DNA sequence in angiosarcoma. Am J Pathol 1996, 149:1363.
409. Rettig MB, Ma HJ, Vescio RA, et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 1997, 276:1851.
410. Kaposi M Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syph 1872, 4:265.
411. Costa de Cunha CS, Lebbe C, Rybojad M, et al. Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alpha-2b. Arch Dermatol 1996, 132:285.
412. Brooks JJ Kaposi's sarcoma: A reversible hyperplasia. Lancet 1986, 2:1309.
413. Kaaya EE, Parravicini C, Ordonez C, et al. Heterogeneity of spindle cells in Kaposi's sarcoma-Comparison of cells in lesions and in culture. J Acquir Immune Defic Synd Hum Retrovirol 1995, 10:295.
414. Rabkin CS, Bedi G, Musaba E, et al. AIDS-related Kaposi's sarcoma is a clonal neoplasm. Clin Cancer Res 1995, 1:257.
415. Wahman A, Melnick SL, Rhame FS, et al. The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma. Epidemiol Revs 1991, 13:178.
416. Hutt MSR Kaposi's sarcoma. Br Med Bull 1984, 40:355.
417. Harwood AR, Osoba D, Hofstader SL, et al. Kaposi's sarcoma in recipients of renal transplants. Am J Med 1979, 67:759.
418. Trattner A, Hodak E, David M, et al. The appearance of Kaposi's sarcoma during corticosteroid therapy. Cancer 1993, 72:1779.
419. Friedman-Kien AE, Saltzman BR Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J Acad Dermatol 1990, 22:1237.
420. Drew WL, Sweet ES, Miner RC, et al. Multiple infections by cytomegalovirus in patients with acquired immune deficiency syndrome: Documentation by Southern blot hybridization. J Infect Dis 1984, 150:952.
421. Giraldo G, Beth E, Vogel CL, et al. Kaposi's sarcoma: A new model in the search for viruses associated with human malignancies. J Natl Cancer Inst 1972, 49:1495.
422. Miles SA, Rezai AR, Salazar-Gonzalez JF, et al. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 1990, 87:4068.
423. Fiorelli V, Gendelman R, Samaniego F, et al. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 1995, 95:1723.
424. Samaniego F, Markham PD, Gallo RC, et al. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcomalike lesion formation in nude mice. J Immunol 1995, 154:3582.
425. Ensoli B, Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 1994, 371:674.
426. Radka SF, Nakamura S, Sakurada S, et al. Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma. J Immunol 1993, 150:5195.
427. Huang YQ, Li JJ, Rush MG, et al. HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet 1992, 339:515.
428. Barillari G, Gendelman R, Gallo RC, et al. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi's sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA 1993, 90:7941.
429. Reizis Z, Tattner A, Katzenelson V, et al. Flow cytometric DNA analysis of classic and steroid-induced Kaposi's sarcoma. Br J Dermatol 1995, 132:548.
430. Eto H, Toriyama K, Tsuda N, et al. Flow cytometric DNA analysis of vascular soft tissue tumors, including African endemic-type Kaposi's sarcoma. Hum Pathol 1992, 23:1055.
431. Bisceglia M, Bosman C, Quirke P A histologic and flow cytometric study of Kaposi's sarcoma. Cancer 1992, 69:793.
432. Dictor M, Ferno M, Baldetorp B Flow cytometric DNA content in Kaposi's sarcoma by histologic stage. Comparison with angiosarcoma. Anal Quant Cytol Histol 1991, 13:201.
433. Rabkin CS, Bedi G, Musaba E, et al. AIDS-related Kaposi's sarcoma is a clonal neoplasm. Clin Cancer Res 1995, 1:257.
434. Albini A, Aluigi MG, Benelli E, et al. Oncogenesis in HIV-infection: KSHV and Kaposi's sarcoma. Int J Oncol 1996, 9:5.
435. Flamand L, Zeman RA, Bryant JL, et al. Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13:194.
436. Castleman B, Iverson L, Mendez V Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956, 9:822.
437. Keller AR, Hocholzer L, Castleman B Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972, 29:670.
438. Cesarman E, Nador R, Knowles DM Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi's sarcoma-associated herpesvirus-like DNA sequences-Reply. N Engl J Med 1996, 334:272.
439. Jin YT, Tsai ST, Yan JJ, et al. Presence of human herpesvirus-like DNA sequence in oral Kaposi's sarcoma. A preliminary PCR study. Oral Surg Oral Med Oral Pathol Oral Radiol & Endod 1996, 81:442.
440. Walts AE, Shintaku IP, Said JW Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. Am J Clin Pathol 1990, 94:170.
441. Karcher DS, Dawkins F, Garett CT, et al. Body cavity based non-Hodgkin's lymphoma (NHL) in HIV-infected patients: B-cell lymphoma with unusual clinical, immunophenotypic, and genotypic features. Lab Invest 1992, 66:80.
442. Said W, Chien K, Takeuchi S, et al. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: Ultrastructural demonstration of herpesvirus in lymphoma cells. Blood 1996, 87:4937.
443. Nador RG, Cesarman E, Knowles DM Herpes-like DNA sequences in a body-cavity based lymphoma in an HIV-negative patient. Lancet 1995, 333:943.
444. Vescio RA, Lichtenstein AK, Berenson JR Myeloma, macroglobulinemia, and heavy chain disease. Cancer Treatment 1995, 1094-1116. WB Saunders, Philadelphia. 4th ed. C.M. Haskell (Ed.).
445. Kyle RA "Benign" monoclonal gammopathy-After 20 to 35 years of follow-up. Mayo Clin Proc 1993, 68:26.
446. Pastore C, Gloghini A, Volpe G, et al. Distribution of Kaposi's sarcoma herpesvirus sequences among lymphoid malignancies in Italy and Spain. Br J Haematol 1995, 91:918.
447. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865.
448. Dupin N, Grandadam M, Calvez V, et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 1995, 345:761.
449. Huang YQ, Li JJ, Kaplan MH, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995, 345:759.
450. Schalling M, Ekman M, Kaaya EE, et al. A role for a new herpesvirus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995, 1:707.
451. Su IJ, Hsu YS, Chang YC, et al. Herpesvirus-like DNA sequence in Kaposi's sarcoma from AIDS and non-AIDS patients in Taiwan. Lancet 1995, 345:722.
452. Boshoff C, Talbot S, Kennedy M, et al. HHV8 and skin cancers in immunosuppressed patients. Lancet 1996, 384:138.
453. Staskus KA, Zhong W, Gebhard K, et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1996, 71:715.
454. Decker LL, Shankar P, Khan G, et al. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 1996, 184:283.
455. Bigoni B, Dolcetti R, de Lellis L, et al. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis 1996, 173:542.
456. Boldogh I, Szaniszlo P, Bresnahan WA, et al. Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus. Clin Infect Dis 1996, 23:406.
457. Koelle DM, Huang M-L, Chandran B, et al. Frequent detection of Kaposi's sarcoma-associated herpesvirus DNA in saliva of human immunodeficiency virus-infected men: Clinical and immunologic correlates. J Infect Dis 1997, 176:94.
458. Vieira J, Huang M-L, Koelle DM, Corey L Transmissible Kaposi's sarcoma associated virus in saliva of men with a history of Kaposi's sarcoma. J Virol 1997, 71:7083.
459. Corbellino M, Bestetti G, Galli M, et al. Absence of HHV-8 in prostate and semen. N Engl J Med 1996, 335:127.
460. Lin JC, Lin SC, Mar EC, et al. Is Kaposi's sarcoma-associated herpesvirus detectable in semen of HIV-infected homosexual men?. Lancet 1995, 346:1601.
461. Monini P, Delellis L, Fabris M, et al. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med 1996, 334:1168.
462. Tasaka TJ, Said JW, Koeffler HP Absence of HHV-8 in prostate and semen. N Engl J Med 1996, 335:123.
463. Corbellino M, Poirel L, Bestetti G, et al. Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma. AIDS Res Hum Retroviruses 1996, 12:651.
464. Harrington WJ, Bagasra O, Sosa CE, et al. Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J Infect Dis 1996, 174:1101.
465. Arvanitakis L, Mesri E, Nador R, et al. Establishment and characterization of a primary effusion lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus in the absence of Epstein-Barr virus. Blood 1996, 88:2648.
466. Mesri EA, Cesarman E, Arvanitakis L, et al. Human herpesvirus-8/ Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 1996, 183:2385.
467. Inagi R, Kosuge H, Nishimoto S, et al. Kaposi's sarcoma-associated herpesvirus (KSHV) sequences in premalignant and malignant skin tumors. Arch Virol 1996, 141:2217.
468. Monini P, Rotola A, de Lellis L, et al. Latent BK virus infection and Kaposi's sarcoma pathogenesis. Int J Cancer 1996, 66:717.
469. Purvis SF, Katangole-Mbidde E, Johnson JL, et al. High incidence of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in tumor lesions and peripheral blood mononuclear cells from patients with Kaposi's sarcoma in Uganda. J Infect Dis 1997, 175:947.
470. Kempf W, Adams V, Pfaltz M, et al. Human herpesvirus type 6 and cytomegalovirus in AIDS-associated Kaposi's sarcoma-No evidence for an etiological association. Hum Pathol 1995, 26:914.
471. Kempf W, Adams V, Hassam S, et al. Detection of human herpesvirus type 6, human herpesvirus type 7, cytomegalovirus and human papillomavirus in cutaneous AIDS-associated Kaposi's sarcoma. Verh Dtsch Ges Pathol 1994, 78:260.
472. Foreman KE, Friborg J, Kong WP, et al. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med 1997, 336:163.
473. Panyutich EA, Said JW, Miles SA Infection of primary dermal microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus. AIDS 1998, 12:467.
474. Flore O, Rafii S, Ely S, et al. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 1998, 394:588.
475. Moses AV, Fish K, Ruhl R, et al: KSHV infects dermal microvascular endothelial cells and induces morphologic and phenotypic changes characteristic of a KS-like phenotype (Abstract). First Annual Meeting on KSHV and Related Agents, Santa Cruz, CA, July 25-28, 1998.
476. Lock MJ, Griffiths PD, Emery VC Development of a competitive polymerase chain reaction for human herpesvirus 8. J Virol Methods 1997, 64:19.
477. Morfeldt L, Torssander J Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients. Scand J Infect Dis 1994, 26:749.
478. Mocroft A, Youle M, Gazzard B, et al. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. AIDS 1996, 10:1101.
479. Rizzieri DA, Liu J, Traweek ST, et al. Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor. Lancet 1997, 349:775.
480. Cattelan AM, Trevenzoli M, Aversa SM Recent advances in the treatment of AIDS-related Kaposi's sarcoma. Am J Clin Dermatol 2002, 3:451.
481. Zalla MJ Kaposi's sarcoma-An update. Dermatol Surg 1996, 22:274.
482. Gay FP, Holden M The herpes encephalitis problem II. J Infect Dis 1993, 53:287.
483. Sabin AB Studies on the B virus: The experimental disease in Macacus rhesus monkeys. Br J Exp Pathol 1934, 15:321.
484. Melnick JL, Banker DD Isolation of B virus (herpes group) from the central nervous system of a rhesus monkey. J Exp Med 1954, 100:181.
485. Killeen AM, Harrington L, Wall LV, et al. Nucleotide sequence analysis of a homologue of herpes simplex virus type 1 gene US9 found in the genome of simian herpes B virus. J Gen Virol 1992, 73:195.
486. Harrington L, Wall LV, Kelly DC Molecular cloning and physical mapping of the genome of simian herpes B virus and comparison of genome organization with that of herpes simplex virus type 1. J Gen Virol 1992, 73:1217.
487. Perelygina L, Zhu L, Zurkuhlen H, et al. Complete sequence and comparative analysis of the genome of herpes B virus (Cercopithecine herpesvirus 1) from a rhesus monkey. J Virol 2003, 77:6167.
488. Keeble SA, Christofinis GJ, Wood W Natural virus B infection in rhesus monkeys. J Pathol Bacteriol 1958, 76:189.
489. Boulter EA The isolation of monkey B virus ( Herpesvirus simiae) from the trigeminal ganglia of healthy seropositive rhesus monkey. J Biol Stand 1975, 3:279.
490. Weigler BJ, Hird DW, Hilliard JK, et al. Epidemiology of cercopithecine herpesvirus 1 (B virus) infection and shedding in a large breeding cohort of rhesus macaques. J Infect Dis 1993, 167:257.
491. Holmes GP, Hilliard JK, Klontz KC, et al. B virus ( Herpesvirus simiae) infection in humans: Epidemiologic investigation of a cluster. Ann Intern Med 1990, 112:833.
492. Freifeld AG, Hilliard J, Southers J, et al. A controlled seroprevalence survey of primate handlers for evidence of asymptomatic herpes B virus infection. J Infect Dis 1995, 171:1031.
493. Hutt R, Guajardo JE, Kalter SS Detection of antibodies to Herpesvirus simiae and Herpesvirus hominis in nonhuman primates. Lab Anim Sci 1981, 31:184.
494. Katz D, Hilliard JK, Eberle R, et al. ELISA for detection of group-common and virus-specific antibodies in human and simian sera induced by herpes simplex and related simian viruses. J Virol Methods 1986, 14:99.
495. Norcott JP, Brown DW Competitive radioimmunoassay to detect antibodies to herpes B virus and SA8 virus. J Clin Microbiol 1993, 31:931.
496. Scinicariello F, English WJ, Hilliard J Identification by PCR of meningitis caused by herpes B virus. Lancet 1993, 341:1660.
497. Weigler BJ, Scinicariello F, Hilliard JK Risk of venereal B virus (cercopithecine herpesvirus 1) transmission in rhesus monkeys using molecular epidemiology. J Infect Dis 1995, 171:1139.
498. Cohen JI, Davenport DS, Stewart JA, et al. Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1). Clin Infect Dis 2002, 35:1191.
499. Boulter EA, Zwartouw HT, Thornton B Postexposure immunoprophylaxis against B virus ( Herpesvirus simiae) infection. BMJ 1981, 283:1495.
500. Palmer AE B-virus, Herpesvirus simiae: Historical perspective. J Med Primatol 1987, 16:99.
501. Holmes GP, Chapman LE, Stewart JA, et al. Guidelines for the prevention and treatment of B-virus infections in exposed persons. The B Virus Working Group. Clin Infect Dis 1995, 20:421.